User profiles for Tanja Schneider

Tanja Schneider

Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn
Verified email at uni-bonn.de
Cited by 8928

A new antibiotic kills pathogens without detectable resistance

LL Ling, T Schneider, AJ Peoples, AL Spoering… - Nature, 2015 - nature.com
Antibiotic resistance is spreading faster than the introduction of new compounds into clinical
practice, causing a public health crisis. Most antibiotics were produced by screening soil …

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II

T Schneider, T Kruse, R Wimmer, I Wiedemann, V Sass… - Science, 2010 - science.org
Host defense peptides such as defensins are components of innate immunity and have retained
antibiotic activity throughout evolution. Their activity is thought to be due to amphipathic …

Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains

…, JE Bandow, HG Sahl, T Schneider… - Proceedings of the …, 2016 - National Acad Sciences
Daptomycin is a highly efficient last-resort antibiotic that targets the bacterial cell membrane.
Despite its clinical importance, the exact mechanism by which daptomycin kills bacteria is …

Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall

AS Bayer, T Schneider, HG Sahl - … of the New York Academy of …, 2013 - Wiley Online Library
The bactericidal, cell membrane–targeting lipopeptide antibiotic daptomycin (DAP) is an
important agent in treating invasive Staphylococcus aureus infections. However, there have …

Human β-defensin 3 inhibits cell wall biosynthesis in Staphylococci

V Sass, T Schneider, M Wilmes, C Körner… - Infection and …, 2010 - Am Soc Microbiol
Human β-defensin 3 (hBD3) is a highly charged (+11) cationic host defense peptide, produced
by epithelial cells and neutrophils. hBD3 retains antimicrobial activity against a broad …

An oldie but a goodie–cell wall biosynthesis as antibiotic target pathway

T Schneider, HG Sahl - International Journal of Medical Microbiology, 2010 - Elsevier
Bacterial cell wall biosynthesis represents the target pathway for penicillin, the first antibiotic
that was clinically applied on a large scale. Penicillin, by means of its beta-lactam ring, …

[PDF][PDF] Hemodynamic forces tune the arrest, adhesion, and extravasation of circulating tumor cells

…, A Kemmling, S Siemonsen, T Schneider… - Developmental cell, 2018 - cell.com
Metastatic seeding is driven by cell-intrinsic and environmental cues, yet the contribution of
biomechanics is poorly known. We aim to elucidate the impact of blood flow on the arrest and …

[HTML][HTML] Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids

…, M Strach, HG Sahl, U Kubitscheck, T Schneider - Nature …, 2020 - nature.com
The lipopeptide daptomycin is used as an antibiotic to treat severe infections with gram-positive
pathogens, such as methicillin resistant Staphylococcus aureus (MRSA) and drug-…

In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II‐Gly5) of Staphylococcus aureus

T Schneider, MM Senn, B Berger‐Bächi… - Molecular …, 2004 - Wiley Online Library
Staphylococcus aureus peptidoglycan is cross‐linked via a characteristic pentaglycine
interpeptide bridge. Genetic analysis had identified three peptidyltransferases, FemA, FemB and …

MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance

P Staubitz, H Neumann, T Schneider… - FEMS microbiology …, 2004 - academic.oup.com
Frequently bacteria are exposed to membrane-damaging cationic antimicrobial molecules (CAMs)
produced by the host's immune system (defensins, cathelicidins) or by competing …